RBAKDN and cervical squamous cell carcinoma: Rbakdn has been identified as an immune-based signature gene for overall survival in cervical squamous cell carcinoma or a prognosis-related signature gene for colorectal cancer or cervical squamous cell carcinoma (Huang et al., 2020; Sun et al., 2020; Qin et al., 2021).